Showing all 2 results

• 

  Multiple myeloma , Lymphoma

  Lenalidomide

  【Product name】Revlimid

  [English common name]Lenalidomide

  [Chinese common name]Lenalidomide

  [English name]Lenalidomide

  [Chinese other name]Laminamide

  [Indications] This product is combined with dexamethasone to treat at least one therapy.Multiple myelomaAdult patient.

  【Dosage】
  Treatment medication must be initiated and provided under the supervision of a physician with multiple myeloma treatment experience.
  If the patient's absolute neutrophil count (ANC) is <1.0×109/L, or the patient's platelet count is <50×109/L, and the proportion of plasma cells in the bone marrow is less than 50%, or the patient's platelets Counting <30×109/L, and the ratio of plasma cells to nucleated cells in the bone marrow is >50%, then the treatment of this product should not be started.
  Recommended dose
  The recommended starting dose for this product is 25mg. On the 1st to 21st days of each repeated 28-day cycle, 25 mg of this product was orally administered daily until the disease progressed. The recommended dose of dexamethasone is oral administration of 40 mg of dexamethasone on days 1, 8, 15, and 22 of the 28-day treatment cycle.

  [Storage] Store at 20 ° C – 25 ° C (68 ° F – 77 ° F); allow for offset 15 ° C – 30 ° C (59 ° F – 86 ° F).

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Acute T cell lymphoblastic leukemia , Lymphoma

  Nairabin

  【Product name】Arranon

  [English common name]Nelarabine

  [Chinese common name]Nairabin

  [English name]Nelzarabine [USAN]

  [Chinese other name]Nairabine intermediate

  [indications]
  Nairabin injection: used to relapse or not respond to drugs after at least two chemotherapy treatmentsT cell acute lymphoblastic leukemiawithT cell lymphomapatient.
  Nairabine injection: ARRANON is a nucleoside metabolism inhibitor for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoma whose disease does not respond or recur after treatment with at least two chemotherapy regimens. This use is based on the induction of complete reactions. Randomized trials demonstrating increased survival or other clinical benefits have not been performed.

  【Dosage】
  Nairabin injection: adult recommended dose of 1500 mg / m2, intravenous infusion for 2 hours, 21 days for a course of treatment, administered on days 1, 3, 5, without dilution.
  The recommended dose for children is 650 mg/m2, intravenous infusion for 1 hour, 21 days for one course of treatment, continuous infusion for 5 days without dilution.
  Nairabine injection: Adult dose: 1,500 mg/m2, intravenously every 21 days for 2 hours on days 1, 3 and 5.
  Pediatric dose: 650 mg/m2, intravenous injection for 1 hour per day for 5 consecutive days, repeated every 21 days.

  [Storage]Store Arranon injection at 25oC (77oF); Allows offsets from 15oC to 30oC (59oF to 86oF).

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.